Template:Amphotericin B: Difference between revisions

Jump to navigation Jump to search
Ahmed Zaghw (talk | contribs)
Created page with "{| style="margin: 0 0 3em 3em; border: 1px solid #696969; float: right; width:20em" cellpadding="0" cellspacing="0"; ! style="padding: 0 5px; font-size: 100%; background:#F8F8..."
 
Gerald Chi (talk | contribs)
mNo edit summary
 
(One intermediate revision by one other user not shown)
Line 2: Line 2:
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Amphotericin B|{{fontcolor|#6C7B8B|Amphotericin B}}]]'''''
! style="padding: 0 5px; font-size: 100%; background:#F8F8FF" align=center | '''''[[Amphotericin B|{{fontcolor|#6C7B8B|Amphotericin B}}]]'''''
|-
|-
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ZZZZZ<sup>®</sup> FDA Package Insert
! style="padding: 0 5px; font-size: 85%; background:#F5F5F5" align=left | ABELCET<sup>®</sup> FDA Package Insert
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Amphotericin B description|Description]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Amphotericin B description|Description]]
Line 21: Line 21:
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Amphotericin B overdosage|Overdosage]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Amphotericin B overdosage|Overdosage]]
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Amphotericin B clinical studies|Clinical Studies]]
|-
|-
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Amphotericin B dosage and administration|Dosage and Administration]]
! style="font-size: 80%; padding: 0 5px; background: #DCDCDC" align=left |[[Amphotericin B dosage and administration|Dosage and Administration]]

Latest revision as of 05:06, 12 January 2014